DSIJ Mindshare

Previously, the company received an EPC order for a value of approx. Rs 360 crore for a project in India and another order was Rs 826 crore for the design, construction and commissioning of 1 GW p project. Including all the orders to date, the company’s order book stands at over Rs 7,200 crore.

Pharma Intermediates took the lead, contributing 84.0 per cent, followed by Specialty Chemicals at 16.0 per cent. 

According to the standalone annual results, the net sales increased by 12.43 per cent to Rs 2,503.75 crore and the net profit increased by 90.02 per cent to Rs 104.10 crore in FY23 over FY22. The EPS for FY23 stood at Rs 11.07. The company has a market cap of over Rs 2,200 crore.

According to the quarterly results and annual results, the company reported positive numbers. The net sales increased by 13 per cent to Rs 342 crore in Q1FY24 compared to net sales of Rs 303 crore in Q1FY23. The company reported a net profit of Rs 57 crore in Q1FY24 compared to a net profit of Rs 63 crore in the same quarter last year.

According to the consolidated annual results, the company reported net sales of Rs 65.99 crore, operating profit of Rs 3.40 crore, PBT of Rs 2.90 and PAT of Rs 2.17 crore in FY23. The company's share capital was split from 10 shares with a face value of Rs 10 each to 10 shares with a face value of Rs 1 each. The stock split took effect on April 25, 2023.